100 Dots Connected: Reflecting on Eight Years of Conversations
The first edition of "Connecting the Dots" was published on September 29, 2017.…
Assuming the Role of Patient
As readers of The NemetzGroup newsletter know, we often use this space to…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those…
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations were expansive, workshops…
Rare Disease Day … The Power of Many Voices
Rare Disease Day unites this wide range of conditions under one shared umbrella, fostering a global community that amplifies the collective voice.
The Basics of Gratitude
Reflecting on the basics of gratitude can help us find perspective and appreciate the good in our lives.
The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around as a buzzword (or buzz…
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug development projects. By…
Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and apps—built for mindfulness and…
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and commercialization of new drugs.
Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding clinical and commercial…